Tag: Cytokine Release Syndrome

CytoAgents Completes Cohort 1 Dose-Escalation in Clinical Phase 1B for Cytokine Release Syndrome Research

April 26, 2025

CytoAgents Inc., a clinical-stage biotechnology company developing CTO1681 for the prevention and treatment for Cytokine Release Syndrome (CRS), announced the successful completion of the first

ActiGraph Accelerates Clinical Trial Modernization

ActiGraph Boosts Clinical Trial Modernization with Biofourmis Acquisition

January 8, 2025

ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis

Categories

Tag: Cytokine Release Syndrome

CytoAgents Completes Cohort 1 Dose-Escalation in Clinical Phase 1B for Cytokine Release Syndrome Research

ActiGraph Boosts Clinical Trial Modernization with Biofourmis Acquisition

Share With

Recent Posts

Nuclear Care Partners Backs Bipartisan Bill for Energy Workers’ Care

Lake Chelan Health Enters into Prime Vendor Agreement with Medline

Health Technology Insights: Latest News And Innovations – Roundup

INOVIO Announces Pricing of $25 Million Public Offering

Rhode Island Creates Rare Disease Advisory Council

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands